Tag: EBIO

Blue Horseshoe Stocks: XGTI Review & More

xG Technology, Inc. XGTI

We’ve seen XGTI make its way up nicely from a low of .08 subsequent to our tag of the stock late last month, but despite it already being up considerably, we reinforced our bullish opinion of it in yesterday morning’s premarket report.

The momentum we’d observed was sufficient to surmise that further opportunities could be in the cards, and our assumption was accurate indeed. We saw a strong move out of XGTI to begin the session as it traded in its full daily range from an early low of .1021 on up to a new high of .165 for an initial rip of 62%

Midday saw a pullback in the stock, which ultimately found support at .1217 before returning to .155, an added 27% swing, so there was a good chance for late-comers as well. It brought the cumulative total on northward movement for the day to a respectable 89%

Pernix Therapeutics Holdings, Inc. PTX

PTX is another one we’ve tracked in the past which we re-alerted this week on the heels of a newly-registered 52-week low on Friday. The stock made a nice move on Monday, and continued its ascent yesterday.

We witnessed a trading range from .98-1.25 which works out to a solid 28% upswing on the day, and it came on more than eight times the 3-month average volume.

Cerebain Biotech, Inc. CBBT

We tagged CBBT based on observing some abnormal volume on Monday, and despite sliding for the first half of the day, the stock did register a higher low and higher high from the session prior en route to a nice intraday swing. It traded from .53-.86, making a 62% pop and closing with strength at .85.

The company also announced yesterday that it would apply for FDA approval on its medical device which is meant to treat alzheimer’s and dementia sufferers, so that will be one storyline to continue following. (>>Read PR)

Extended Watchlist:
TTCM, HEMP, NTRI, ETSY, Z, EBIO(>>News)

Blue Horseshoe Stocks: TLOG Recap, Options & More

TetraLogic Pharmaceuticals Corp. TLOG

We pointed out what we felt was an interesting chart on TLOG yesterday morning in our premarket report, and the stock ended up being our top performer of the day.

We witnessed an intraday run from .31 to .62, a perfect 100% double-bag rip and it came on roughly 16.5X the three-month average trading volume. The stock ended the day at .49, sustaining more than half of its daily advance into the close. That puts us on momentum alert for the possibility of another solid session today.

Remember, there’s still an enormous gap to fill on the chart from around .65-1.50, so if we can see a testing of the lower limits of that gap, things could get mighty interesting with TLOG really quickly. We’ll be sure to stay on alert.

BP plc (BP) – Options Idea

After an interesting mixed-result earnings release in which BP reported an 80% slide in profits for Q1, yet still managed to beat estimates, we’re seeing an interesting bit of premarket activity. With the stock having gapped up roughly a dollar, we’re going to go ahead and signal a range of options that should fare well if the sentiment in early trading prevails during the session.

Of course we’ll have to keep our eyes peeled for an early dip-and-rip, but if things unfold the way we suspect they may, we’ll be very interested in tracking the BP Weekly $32-33.50 for potential daytrade/swing trade chances as we head into midweek.

Eleven Bio-Therapeutics, Inc. EBIO – Update

We also want to track back to a call we made on Friday, April 15th, suggesting our readers watch the stock into last week, and it ended making an excellent six-session Friday-to-Friday swing of 227%

The stock ran from a low of .52 to 1.70, and just began to consolidate yesterday as we kicked off the new trading week. Now that we’ve followed EBIO on the way up, we’ll continue to monitor it as it comes down, staying ready for any bounceplay opportunities that might present themselves.

Extended Watchlist:
STEV, ONOV, HPTG, EARI(Bottom-bouncer)

Blue Horseshoe Stocks: SNTA Recap, Options & More

Synta Pharmaceuticals Corp. SNTA

After catching a PR containing some big merger news for SNTA yesterday morning, we decided to include the stock in our premarket report, and it turned out to be a good decision.

On just under 12X the 3-month average trading volume, SNTA ran from a daily low of .32 up to .45 inside of the first 90 minutes of the session. That registered as a respectable intraday spike of 41% As measured to this morning’s premarket high of .488, that figure is extended to 53%

We’ll have our eyes peeled for another push this morning. The type of volume that we witnessed yesterday coupled with the stock holding more than 50% of its daily gains, puts SNTA into the category of a possible momentum play.

______

Bonus Pharma Watchlist:

We are also going to be monitoring the activity in a couple of other pharma stocks in coming sessions:  Aoxing Pharmaceutical Co., Inc. AXN and Eleven Biotherapeutics, Inc. EBIO

EBIO is reportedly another reverse-merger candidate that caught a wave of momentum on the heels of yesterday’s big news, and AXN is showing a double-bottom signal and has been making headway trading up off of its lows for the past few sessions. We’ll want to monitor both of these plays into next week.

SPDR S&P 500 ETF (SPY) – Fresh Options Idea

It wouldn’t be a typical Friday without a end-of-week options idea, so we’re going to turn to one of our classic targets- the SPY. Here in the premarket we’ve observed a low of 207.58. How we’ll want to play it is this: Should the SPY maintain support at 207.50 or above on any early pullbacks, we’re going to be interested in the Weekly $207.50-208 Calls. In the event it fails to hold support a that point, we’ll look to the Weekly $208-207.50 Puts.

*CAUTION: Trading weekly options on Friday is commonly a very high risk proposition. To be attempted by advanced traders only!

Extended Watchlist:
SUNE, LNCO, LINE, VSLR, EBIX, DRWI, AXPW(Bottom-Watcher)